Thursday - February 26, 2026

Metastatic Colorectal Cancer Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Daiichi Sankyo Company, Mirati Therapeutics, Apollomics, Treos Bio

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Metastatic Colorectal Cancer pipeline constitutes 150+ key companies continuously working towards developing 180+ Metastatic Colorectal Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading

EGVIRTUAL LLC Launches Luxe Vida Wellness to Revolutionize Recovery for Elite Athletic Recovery and Performance as well as Personal Wellness with Medical-Grade Technology.

We recognized a significant gap in the market for truly medical-grade wellness solutions that elite performers could integrate into their daily routines without compromising on quality or effectiveness. Luxe Vida Wellness bridges that gap by offering the same caliber of … Continue reading

Biliary Tract Cancer Market: Expanding Revenue Landscape to 2034 – DelveInsight | AstraZeneca, Taiho Oncology, Delcath Systems, TransThera Sciences (Nanjing), Basilea Pharma, Eisai, Merck

The Key Biliary Tract Cancer Companies in the market include – Merck Sharp & Dohme, AstraZeneca, Taiho Oncology, Delcath Systems, TransThera Sciences (Nanjing), Basilea Pharmaceutica, Eisai, Zymeworks, BeiGene, Xencor, Inc., Bristol-Myers Squibb, Leap Therapeutics, Compass Therapeutics, Boehringer Ingelheim, ZielBio, Inc., … Continue reading